Efficacy and tolerability of long-term oral cefaclor therapy in the prevention of urinary tract infections in infants and children

Current Therapeutic Research - Clinical and Experimental

Volumn 59, Issue 12, 1998, Pages 873-880

  Canepa, Alberto ^a   Galardi, Federica ^a   Gusmano, Rosanna ^a   Mattioli, Francesca ^b   Martelli, Antonietta ^b  

^a G GASLINI INSTITUTE   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

Efficacy; Pediatrics; Prolonged cefaclor therapy; Tolerability; Urinary tract infections

Indexed keywords

CEFACLOR;

ARTICLE; CHILD; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; MALE; MINIMUM INHIBITORY CONCENTRATION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REINFECTION; SIDE EFFECT; URINARY TRACT INFECTION;

EID: 0032412315     PISSN: 0011393X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0011-393X(98)85052-2     Document Type: Article

References (15)

1. Agbayani MM, Khan AJ, Kumar K, et al. Cefaclor therapy of urinary tract infection in infants and children. Curr Ther Res. 1979;26:141-144.
2. Cox CE. Cefaclor therapy of urinary tract infections. Curr Ther Res. 1980;27:337-340.
3. Greenberg RN, Sanders CV, Lewis AC, Marier RL. Single-dose cefaclor therapy of urinary tract infection. Evaluation of antibody-coated bacteria test and C-reactive protein assay as predictors of cure. Am J Med. 1981;71:841-845.
4. Verhoef J. Cefaclor in the treatment of skin, soft tissue, and urinary tract infections: A review. Clin Ther. 1988;11:71-82.
5. Kovach PM, Lantz RI, Brier G. High-performance liquid Chromatographic determination of loracarbef, a potential metabolite, cefaclor and cephalexin in human plasma, serum and urine. J Chromatogr. 1991;567:129-139.
6. Foglesong MA, Lamb JW, Dietz JV. Stability and blood level determinations of cefaclor, a new oral cephalosporin antibiotic. Antimicrob Agents Chemother. 1978;13:49-52.
7. Wieling J, Hendriks G, Tamminga WJ, et al. Rational experimental design for bioanalytical methods validation. Illustration using an assay method for total captopril in plasma. J Chromatogr. 1996;730:381-394.
8. Meyers BR, Hirschman SZ, Wormser G, et al. Pharmacologic studies with cefaclor, a new oral cephalosporin. J Clin Pharmacol. 1978;18:174-179.
9. Mirrett S, Barth Reller L. Comparative activity in vitro of cefaclor, cephalexin and cephradine. Curr Ther Res. 1979;26:145-151.
10. McCracken G. Diagnosis and management of acute urinary tract infections in infants and children. Pediatr Infect Dis J. 1987;6:107-112.
11. Ogra P, Faden H. Urinary tract infections in childhood: An update. J Pediatr. 1985;106: 1023-1028.
12. Sides GD, Franson TR, DeSante KA, Black HR. A comprehensive review of the clinical pharmacology and pharmacokinetics of cefaclor. Clin Ther. 1988;11:5-18.
13. McCracken GH, Ginsburg CM, Clahsen JC, Thomas ML. Pharmacokinetics of cefaclor in infants and children. J Antimicrob Chemother. 1978;4:515-521.
14. Lindan R. Comparison of cefaclor and amoxycillin in the treatment of urinary infections in a chronic disease hospital. Postgrad Med J. 1979;55(Suppl 4):67-69.
15. Iravani A, Richard GA. A combination of amoxicillin and clavulanic acid versus cefaclor in the treatment of urinary tract infections of adolescent girls. Clin Res. 1982;30:369A.